Blog
-
EU pharmaceutical regulations and market access
Why can a drug be approved across the EU but still be unavailable to patients? This interactive group chat explainer walks you through pharmaceutical pricing, reimbursement, HTA, and IP protection -featuring all key stakeholders from EMA to patient voices.
-
From AlphaFold to AIDO: The Evolution of AI-Driven Biology
From Molecular Prediction to Systems-Level Biological Intelligence Computational Biology · AI From Molecular Prediction to Systems-Level Biological Intelligence AlphaFold gave us the parts list. The next generation of biological AI aims to understand how those parts build living systems. Contents AlphaFold’s Revolutionary Impact The DeepMind Biological AI Ecosystem Why These Tools Matter The Limits of…
-
EU Horizon Europe Research Funding: Data, Trends, and Networks
EU Horizon Europe Research Funding: Data, Trends, and Networks Research Funding · Data Analysis EU Horizon Europe Research Funding: Data, Trends, and Networks An analysis of the global distribution of funds, institutional collaboration, and research topics across the 2021–2027 funding period. September 2025 · Based on CORDIS Horizon Europe datasets Contents Which Countries Participate? Most…